Literature DB >> 34687697

CaMKIIα knockout protects from ischemic neuronal cell death after resuscitation from cardiac arrest.

Nicole L Rumian1, Nicholas E Chalmers2, Jonathan E Tullis3, Paco S Herson4, K Ulrich Bayer5.   

Abstract

CaMKIIα plays a dual role in synaptic plasticity, as it can mediate synaptic changes in opposing directions. We hypothesized that CaMKIIα plays a similar dual role also in neuronal cell death and survival. Indeed, the CaMKII inhibitor tatCN21 is neuroprotective when added during or after excitotoxic/ischemic insults, but was described to cause sensitization when applied long-term prior to such insult. However, when comparing long-term CaMKII inhibition by several different inhibitors in neuronal cultures, we did not detect any sensitization. Likewise, in a mouse in vivo model of global cerebral ischemia (cardiac arrest followed by cardiopulmonary resuscitation), complete knockout of the neuronal CaMKIIα isoform did not cause sensitization but instead significant neuroprotection.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CaMKII; Cardiac arrest; Cardiopulmonary resuscitation; Excitotoxicity; Ischemia; Neuronal cell death

Mesh:

Substances:

Year:  2021        PMID: 34687697      PMCID: PMC8985230          DOI: 10.1016/j.brainres.2021.147699

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  34 in total

1.  Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice.

Authors:  A J Silva; C F Stevens; S Tonegawa; Y Wang
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

2.  CaMKII autonomy is substrate-dependent and further stimulated by Ca2+/calmodulin.

Authors:  Steven J Coultrap; Isabelle Buard; Jaqueline R Kulbe; Mark L Dell'Acqua; K Ulrich Bayer
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

3.  Excitotoxic neuroprotection and vulnerability with CaMKII inhibition.

Authors:  Nicole M Ashpole; Andy Hudmon
Journal:  Mol Cell Neurosci       Date:  2011-02-21       Impact factor: 4.314

4.  Regulation of brain type II Ca2+/calmodulin-dependent protein kinase by autophosphorylation: a Ca2+-triggered molecular switch.

Authors:  S G Miller; M B Kennedy
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

5.  Calmodulin kinase II inhibition protects against structural heart disease.

Authors:  Rong Zhang; Michelle S C Khoo; Yuejin Wu; Yingbo Yang; Chad E Grueter; Gemin Ni; Edward E Price; William Thiel; Silvia Guatimosim; Long-Sheng Song; Ernest C Madu; Anisha N Shah; Tatiana A Vishnivetskaya; James B Atkinson; Vsevolod V Gurevich; Guy Salama; W J Lederer; Roger J Colbran; Mark E Anderson
Journal:  Nat Med       Date:  2005-03-27       Impact factor: 53.440

6.  Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor.

Authors:  Rebekah S Vest; Heather O'Leary; Steven J Coultrap; Mark S Kindy; K Ulrich Bayer
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

7.  Autonomous CaMKII mediates both LTP and LTD using a mechanism for differential substrate site selection.

Authors:  Steven J Coultrap; Ronald K Freund; Heather O'Leary; Jennifer L Sanderson; Katherine W Roche; Mark L Dell'Acqua; K Ulrich Bayer
Journal:  Cell Rep       Date:  2014-01-30       Impact factor: 9.423

8.  Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning.

Authors:  K P Giese; N B Fedorov; R K Filipkowski; A J Silva
Journal:  Science       Date:  1998-02-06       Impact factor: 47.728

9.  A significant but rather mild contribution of T286 autophosphorylation to Ca2+/CaM-stimulated CaMKII activity.

Authors:  Steven J Coultrap; Kelsey Barcomb; K Ulrich Bayer
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

10.  CaMKII versus DAPK1 Binding to GluN2B in Ischemic Neuronal Cell Death after Resuscitation from Cardiac Arrest.

Authors:  Olivia R Buonarati; Sarah G Cook; Dayton J Goodell; Nicholas E Chalmers; Nicole L Rumian; Jonathan E Tullis; Susana Restrepo; Steven J Coultrap; Nidia Quillinan; Paco S Herson; K Ulrich Bayer
Journal:  Cell Rep       Date:  2020-01-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.